Cargando…

Assessment of Repetitive and Compulsive Behaviors Induced by Pramipexole in Rats: Effect of Alpha-Synuclein-Induced Nigrostriatal Degeneration

Treatment with dopamine agonists in Parkinson’s disease (PD) is associated with debilitating neuropsychiatric side-effects characterized by impulsive and compulsive behaviors. The vulnerability to develop such impairments is thought to involve interactions between individual vulnerability traits, ty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Decourt, Mélina, Balado, Eric, Jiménez-Urbieta, Haritz, Francheteau, Maureen, Fernagut, Pierre-Olivier, Benoit-Marand, Marianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945858/ https://www.ncbi.nlm.nih.gov/pubmed/35327343 http://dx.doi.org/10.3390/biomedicines10030542

Ejemplares similares

Premorbid performances determine the deleterious effects of nigrostriatal degeneration and pramipexole on behavioural flexibility
por: Decourt, Mélina, et al.
Publicado: (2023)

Neuropsychiatric and Cognitive Deficits in Parkinson’s Disease and Their Modeling in Rodents
por: Decourt, Mélina, et al.
Publicado: (2021)

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
por: Mor, Danielle E., et al.
Publicado: (2017)

Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression
por: Bourdenx, Mathieu, et al.
Publicado: (2015)

Pramipexole Reduces Phosphorylation of α-Synuclein at Serine-129
por: Chau, Kai-Yin, et al.
Publicado: (2013)

Hypodopaminergic state of the nigrostriatal pathway drives compulsive alcohol use
por: Goutaudier, Raphaël, et al.
Publicado: (2022)

Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse
por: Song, Lian-Kun, et al.
Publicado: (2015)

Microglial depletion does not impact alpha-synuclein aggregation or nigrostriatal degeneration in the rat preformed fibril model
por: Stoll, Anna C., et al.
Publicado: (2023)

Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit
por: Tozzi, Alessandro, et al.
Publicado: (2021)

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
por: Lee, Seung Ha, et al.
Publicado: (2017)

A metabolic biomarker predicts Parkinson’s disease at the early stages in patients and animal models
por: Mallet, David, et al.
Publicado: (2022)

Commentary: Dopamine-Dependent Early Synaptic and Motor Dysfunctions Induced by α-Synuclein in the Nigrostriatal Circuit
por: Zhang, Jiahui, et al.
Publicado: (2021)

Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration
por: Mannino, Deborah, et al.
Publicado: (2023)

Nigrostriatal dynein changes in A53T alpha-synuclein transgenic mice
por: Liu, Yan, et al.
Publicado: (2014)

Effects of pramipexole treatment on the α-synuclein content in serum exosomes of Parkinson's disease patients
por: Luo, He-Ting, et al.
Publicado: (2016)

Impact of α‐synuclein spreading on the nigrostriatal dopaminergic pathway depends on the onset of the pathology
por: Sun, Fanfan, et al.
Publicado: (2021)

Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease
por: Gou, De-Hai, et al.
Publicado: (2020)

Subthalamic Nucleus Deep Brain Stimulation Does Not Modify the Functional Deficits or Axonopathy Induced by Nigrostriatal α-Synuclein Overexpression
por: Fischer, D. Luke, et al.
Publicado: (2017)

High-degree atrioventricular heart block induced by pramipexole
por: Kanal, Yücel, et al.
Publicado: (2022)

GDNF-mediated rescue of the nigrostriatal system depends on the degree of degeneration
por: Quintino, Luis, et al.
Publicado: (2018)

No apparent transmission of transgenic α–synuclein into nigrostriatal dopaminergic neurons in multiple mouse models
por: Sastry, Namratha, et al.
Publicado: (2015)

Motor Impairments Correlate with Social Deficits and Restricted Neuronal Loss in an Environmental Model of Autism
por: Al Sagheer, Tareq, et al.
Publicado: (2018)

Dopamine control of pyramidal neuron activity in the primary motor cortex via D2 receptors
por: Vitrac, Clément, et al.
Publicado: (2014)

Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice
por: Pérez‐Taboada, Iara, et al.
Publicado: (2020)

Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression
por: Wang, Yong, et al.
Publicado: (2020)

Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice
por: Ninkina, Natalia, et al.
Publicado: (2020)

Sex-dependent behavioral deficits and neuropathology in a maternal immune activation model of autism
por: Haida, Obelia, et al.
Publicado: (2019)

Absence of Ret Signaling in Mice Causes Progressive and Late Degeneration of the Nigrostriatal System
por: Kramer, Edgar R, et al.
Publicado: (2007)

Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons
por: Bayliss, Jacqueline A., et al.
Publicado: (2016)

High Dietary Iron Supplement Induces the Nigrostriatal Dopaminergic Neurons Lesion in Transgenic Mice Expressing Mutant A53T Human Alpha-Synuclein
por: Jia, Fengju, et al.
Publicado: (2018)

Pramipexole use and the risk of pneumonia
por: Ernst, Pierre, et al.
Publicado: (2012)

AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease
por: Ip, Chi Wang, et al.
Publicado: (2017)

Pramipexole: new use for an old drug – the potential use of pramipexole in the treatment of restless legs syndrome
por: Benbir, Gulcin, et al.
Publicado: (2006)

Major motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse model
por: Matas, Emmanuel, et al.
Publicado: (2021)

Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
por: Hou, Lijuan, et al.
Publicado: (2017)

Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit
por: Pham, Anh H., et al.
Publicado: (2012)

Metabolic Covariant Network in Relation to Nigrostriatal Degeneration in Carbon Monoxide Intoxication-Related Parkinsonism
por: Chang, Chiung-Chih, et al.
Publicado: (2016)

Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease
por: Wang, Jing, et al.
Publicado: (2020)

Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
por: Morales, Ingrid, et al.
Publicado: (2021)

A Mouse Model of Nigrostriatal Dopaminergic Axonal Degeneration As a Tool for Testing Neuroprotectors
por: Kolacheva, A. A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_efocd91quiehr9genn41nl5mq8